Navigation Links
Fishing for a Speedy Recovery After Chemotherapy or Marrow Transplant

Researchers at Childrens Hospital, Boston, have discovered a novel way of increasing stem cells in blood, that holds promise for patients undergoing chemotherapy and bone marrow transplant.

The recent research on zebra fish has raised hope about its ability to help patients bounce back sooner after treatment for cancer or recuperating post bone marrow transplant. The research is available in detail in the current issue of Nature.

The discovery, made possible through high-volume drug screening in zebra fish, marks the first time stem-cell production has been induced by a small-molecule drug, says the studys senior author, Leonard Zon, MD, of the Childrens Hospital Boston Stem Cell Program and Division of Hematology/Oncology. Other studies, including one from Zon's own lab*, have identified ways of increasing formation of blood stem cells, which give rise to each of the bodys various blood cell types. However, the methods are technically complex and havent lent themselves to broad medical use.

The hospital now hopes to conduct a clinical trial of the drug, a long-active derivative of prostaglandin E2 known as dmPGE2. This compound was originally tested more than 20 years ago for patients with gastritis, but was never marketed as a drug.

Currently, patients undergoing bone marrow transplant must wait for marrow from a matched donor to replenish their stem cells and reproduce the full array of blood cell types, including all the cells of the immune system. When theres no suitable donor for a marrow match, patients can receive umbilical cord blood, which also contains blood stem cells. But the number of stem cells in one cord of blood is often not adequate for older children and adults, leaving them with diminished immune function and high risk for infections.

Zon and colleagues Trista North, PhD, and Wolfram Goessling, MD, PhD, both also of Childrens Stem Cell Program, zeroed in on dmPGE2 by screen
'"/>




Page: 1 2 3

Related medicine news :

1. Just Had Bowel Surgery? Chew Gum For A Speedy Recovery
2. Proper Diagnosis Could Augment Speedy Recovery Of Haglund’s Syndrom
3. Glucose Enables Speedy Recovery From Malaria
4. Amphetamines Help Recovery of Stroke Patients
5. Recovery from lung injury
6. Recovery After Heart Transplantation
7. Combination Therapy Found To Improves Stroke Recovery
8. Swallowing Exercises Helps With Cancer Treatment Recovery
9. Early Detection Of Prostate Cancer For Complete Recovery From Prostate Cancer
10. Breast Cancer Survivors Emotional Recovery Is Rapid After Treatment
11. Face Transplant Patient Jeopardizing Chances of Recovery By Smoking
Post Your Comments:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...e world's leading pharmaceutical companies, issued...improves survival in patients// with metastatic pr...TAX 327 compared Taxotere plus prednisone to Novan...The study included a little over a thousand men wh...
...of malaria, one of the most common vector-borne di...ases in 2005 to 1.2 million cases in 2006, the Eco...ial sectors, the Economic Survey said malaria deat...o 961 people in the country in this period. Accor...
...r-pregnancy pounds should add daily walks and limi... by Harvard researchers. // “The childbearing year... women,” said lead author Emily Oken, M.D. “Modifi...m period — such as diet, television viewing and wa...
...oles in their eardrums could have better success r...ctors at West Virginia University. // The study wa...ngology – Head and Neck Surgery, the official jour...ngology-Head and Neck Surgery Foundation. Conducte...
Other Medicine News:Health News:Incidence of Malaria Has Come Down, Says Economic Survey 2Health News:Simple Solutions to Postpartum Weight Retention 2Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2
(Date:10/9/2008)... Top Line Clinical Results Expected in Novembe...all/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced...sing,for the third of its three pivotal trials to ...n of 12-hour extended-release (ER) ibuprofen for,t...cts to report top-line,results from this pivotal t...
(Date:10/8/2008)... - Findings May Someday Inform Treatments for ..., Oct. 8 /PRNewswire-USNewswire/ -- A protein that...r plays a key role in controlling,the developing n...s precise,connections to form among nerve cells ma...ents who suffer injuries to their nervous system,...
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as...FirstCall/ -- Nventa Biopharmaceuticals,Corporatio...eclinical,studies using its proprietary Toll-like ...R), at the World Vaccine Congress 2008 in Lyon, Fr...potent vaccine adjuvant,targeting the Toll-like Re...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5A South Florida Premiere 22160 1A South Florida Premiere 22160 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 1Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference 22154 2BioSpace Launches EuroBio 28TM 29 Online Community 6074 1BioSpace Launches EuroBio 28TM 29 Online Community 6074 2
...also show evidence of additional protection,agains... LOS ANGELES, April 17, 2007 /PRNewswire-FirstCall... vaccine, CERVARIX(R),demonstrated 100 percent ef...ancer-causing human papillomavirus types 16 and 18...l, according to,data presented today at the Americ...
...USINESS WIRE)--Apr 17, 2007 - Adnexus(TM),Therapeu... abstract,"CT-322: A specific VEGFR-2-blocking pro...l tumor models comparable to pan-specific,tyrosine...b" at the,American Association for Cancer Research...e lead author is Irvith Carvajal, Ph.D., with,Eric...
Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs).
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity.
The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for
Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (
Medicine Products: